Mechanisms of mammalian target of rapamycin inhibition in sarcoma: present and future

被引：13
|
作者：
MacKenzie, Amy R. [1 ]
von Mehren, Margaret [1 ]
机构：
[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
来源：
EXPERT REVIEW OF ANTICANCER THERAPY | 2007年 / 7卷 / 08期
关键词：
AP23573; bone sarcoma; CCI-779; mammalian target of rapamycin; RAD001; sirolimus; soft-tissue sarcoma;
D O I：
10.1586/14737140.7.8.1145
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The mammalian target of rapamycin (mTOR) is a protein kinase that plays a pivotal role in the control of cell growth and development. A part of the PI3K/Akt pathway, mTOR responds to growth factor stimuli as well as nutrient availability by variations in downstream phosphorylation. Increasing knowledge of the upstream regulators and downstream targets of mTOR has led to the development of anticancer drugs that suppress protein synthesis and metabolism. Rapamycin (sirolimus) and three rapamycin analogues are currently being evaluated in clinical trials: temsirolimus (CCI-779, Wyeth), everolimus (RAD001, Novartis Pharma AG), and AP23573 (Ariad Pharmaceuticals Inc.). This review will highlight the role of these inhibitors in the treatment of sarcoma.
引用
收藏
页码：1145 / 1154
页数：10
相关论文
共 50 条
  • [21] Growth Inhibition of Mammalian Target of Rapamycin (MTOR) in Malignant Pleural Mesothelioma
    Agarwal, V.
    Lind, M. J.
    Cawkwell, L.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S140 - S141
  • [22] Mammalian target of rapamycin inhibition as therapy for hematologic malignancies - Author reply
    Giles, FJ
    CANCER, 2004, 101 (06) : 1478 - 1478
  • [23] Mammalian target of rapamycin inhibition as a therapeutic strategy in the management of urologic malignancies
    Garcia, Jorge A.
    Danielpour, David
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (06) : 1347 - 1354
  • [24] INHIBITION OF MAMMALIAN TARGET OF RAPAMYCIN WITH TEMSIROLIMUS CAN ENHANCE ANTITUMOR IMMUNITY
    Wang, Yanping
    Kim, Hyung
    JOURNAL OF UROLOGY, 2012, 187 (04): : E126 - E126
  • [25] Systemic inhibition of mammalian target of rapamycin inhibits fear memory reconsolidation
    Blundell, Jacqueline
    Kouser, Mehreen
    Powell, Craig M.
    NEUROBIOLOGY OF LEARNING AND MEMORY, 2008, 90 (01) : 28 - 35
  • [26] Mammalian target of Rapamycin inhibition and mycobacterial survival are uncoupled in murine macrophages
    Zullo, Alfred J.
    Smith, Kristen L. Jurcic
    Lee, Sunhee
    BMC BIOCHEMISTRY, 2014, 15
  • [27] Molecular Determinants of Outcome With Mammalian Target of Rapamycin Inhibition in Endometrial Cancer
    Mackay, Helen J.
    Eisenhauer, Elizabeth A.
    Kamel-Reid, Suzanne
    Tsao, Ming
    Clarke, Blaise
    Karakasis, Katherine
    Werner, Henrica M. J.
    Trovik, Jone
    Akslen, Lars A.
    Salvesen, Helga B.
    Tu, Dongsheng
    Oza, Amit M.
    CANCER, 2014, 120 (04) : 603 - 610
  • [28] Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy
    Huang, Xiaoxing
    Zhang, Hailong
    Yang, Jun
    Wu, Jingfan
    McMahon, John
    Lin, Yufan
    Cao, Zhonglian
    Gruenthal, Michael
    Huang, Yunfei
    NEUROBIOLOGY OF DISEASE, 2010, 40 (01) : 193 - 199
  • [29] Inhibition of the mammalian target of rapamycin sensitizes glioma cells to anticancer drugs
    Sakurada, K
    Sonoda, Y
    Kitanaka, C
    Mori, W
    Kayama, T
    NEURO-ONCOLOGY, 2005, 7 (03) : 301 - 301
  • [30] Inhibition of mammalian target of rapamycin, alcohol-related memories, and relapse
    不详
    NEUROSCIENTIST, 2014, 20 (01): : 6 - 6
12345